Given Imaging Ltd., an Israeli company that develops capsuled equipped with cameras for visualization of the gastrointestinal tract, has filed with the American Food and Drug Administration (FDA) to get approval for its PillCam Colon 2 Capsule. The capsule is a complementary product for colonoscopies and has a target market of $1.7 billion.
Subscribe to NoCamels weekly newsletter and get our top stories
Facebook comments